Real-world effectiveness of COVID-19 vaccination among children in Italy
In a recent study, Husin and colleagues emphasized the considerable efficacy of the coronavirus disease 2019 (COVID-19) mRNA-based BNT162b2 vaccine against the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adolescents (Husin et al., 2022). Since not only limiting the burden of SARS-CoV-2 infection, but also preventing the risk of developing severe complications of COVID-19 is imperative in childhood, the real-world effectiveness of COVID-19 vaccination among Italian children was investigated in this study.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Camilla Mattiuzzi, Giuseppe Lippi Source Type: research
More News: Children | Coronavirus | Covid Vaccine | COVID-19 | Infectious Diseases | Italy Health | Respiratory Medicine | SARS | Study | Vaccines